Srineon Pharmaceuticals Private Limited

Srineon Pharmaceuticals Private Limited - business services in Bhongiri, Telangana, India. Directors, charges & compliance details.
CIN U46497TS2023PTC179201 Incorporated 20 November 2023 ROC Hyderabad HQ Bhongiri, Telangana, India
Active Private Limited Company
Data last updated
Revenue · FY 2025
₹1.47 Lakh
▲ 30% YoY
Net loss · FY 2025
₹3,289
Net margin -2.2%
EBITDA · FY 2025
-₹3,289
EBITDA margin -2.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
3 yrs
Est. 2023
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Srineon Pharmaceuticals Private Limited

Data last updated:

Srineon Pharmaceuticals Private Limited is a private limited company based in Bhongiri, Telangana, India. It was incorporated on 20 November 2023.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U46497TS2023PTC179201.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Katapally Bhavani and Voruganti Shivani.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bhongiri, Telangana.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.47 Lakh, a growth of 30% compared to the previous year. For the same year it recorded a net loss of ₹3,289 (net margin -2.2%) and EBITDA of -₹3,289 (EBITDA margin -2.2%).

Company details

CIN U46497TS2023PTC179201
Registration Number 179201
Incorporation Date 20 November 2023
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025

Contact details

Srineon Pharmaceuticals Private Limited's registered office is in Bhongiri, Telangana.

  • Registered Address
    H.No.1 – 95, Tajpur Yadadri Bhongri, Bhongiri, Telangana, India – 508116
Comprehensive company report
Srineon Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Srineon Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ6Other Hospital and Medical Care Activities

To see the full business activity and turnover split of Srineon Pharmaceuticals Private Limited, buy the company report.

Financials of Srineon Pharmaceuticals Private Limited

FY 2025 filings available

Srineon Pharmaceuticals Private Limited reported revenue of ₹1.47 Lakh (up 30% YoY) for FY 2025.

Revenue · FY 2025
₹1.47 Lakh ▲ 30%
Net loss · FY 2025
₹3,289 margin -2.2%
EBITDA · FY 2025
-₹3,289 margin -2.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 30%
EBITDA CAGR growth
1 year
▲ 74%

Revenue rose 30% in the latest year. EBITDA rose 74% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹3,289
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹3,289
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24
Profitability
EBITDA Margin-2.2%
Net Profit Margin-2.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Srineon Pharmaceuticals Private Limited, buy the company report.

Board of directors of Srineon Pharmaceuticals Private Limited

Srineon Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Katapally BhavaniDirector20 Nov 20232 Years 11 MonthsCurrent
Voruganti ShivaniDirector20 Nov 20232 Years 11 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Srineon Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Srineon Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Srineon Pharmaceuticals Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Katapally Bhavani was appointed as Director on 20 Nov 2023.

AGM
Srineon Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Srineon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Katapally Bhavani was appointed as Director.
Appointed
Voruganti Shivani was appointed as Director.
Incorporation
20 Nov 2023
Srineon Pharmaceuticals Private Limited was registered on 20 Nov 2023 with Roc Hyderabad & aged 2 years 11 months as per MCA records.

Frequently asked questions

Srineon Pharmaceuticals is an active private limited company based in Bhongiri, Telangana, India. It was incorporated on 20 November 2023 (3+ years old) and is registered under CIN U46497TS2023PTC179201.

Srineon Pharmaceuticals has 2 current directors:

The latest financial statements of Srineon Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.

The CIN (Corporate Identification Number) of Srineon Pharmaceuticals is U46497TS2023PTC179201. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Srineon Pharmaceuticals was incorporated on 20 November 2023, making it 3+ years old. It is registered with the Registrar of Companies, Hyderabad.

Katapally Bhavani was appointed as Director on 20 Nov 2023. Voruganti Shivani was appointed as Director on 20 Nov 2023.

The registered office of Srineon Pharmaceuticals is at H.No.1 – 95, Tajpur Yadadri Bhongri, Bhongiri, Telangana, India – 508116.

Srineon Pharmaceuticals can be reached at its registered office: H.No.1 – 95, Tajpur Yadadri Bhongri, Bhongiri, Telangana, India – 508116.

Srineon Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.